First BanCorp. (NYSE:FBP – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price objective among […]

Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been given an average rating of “Moderate Buy” by the ten brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and eight have assigned a buy rating to […]